Literature DB >> 22551584

Overexpressed DNA-binding protein inhibitor 2 as an unfavorable prognosis factor promotes cell proliferation in nasopharyngeal carcinoma.

Zhen Liu1, Jing Chen, Weiren Luo, Huiling Yang, Aibing Wu, Yan Zhen, Xiaoli Yu, Hao Wang, Kaitai Yao, Xin Li, Weiyi Fang.   

Abstract

The aim of the present study was to analyze the expression of DNA-binding protein inhibitor 2 (ID2) in nasopharyngeal carcinoma (NPC) and its correlation with clinicopathological features. It was found that the expression of ID2 was significantly increased in NPC cells when compared with that in NP69 cell line. Similar level of ID2 cytoplasmic expression was observed in NPC when compared with that in non-cancerous nasopharynx tissues. However, the level of ID2 in nucleus was increased in NPC when compared with that in normal nasopharynx tissues. Furthermore, the higher expression level of nuclear ID2 was significantly associated with tumor size (T classification), lymph node metastasis (N classification), and clinical stage. Patients with increased ID2 expression level had poorer overall survival rates than those with low ID2 levels. The inhibition of ID2 expression in NPC cell line SUNE1 by lentiviral-mediated short hairpin RNA could suppress cell proliferation and colony formation, but did not disrupt cell migration. Knocking down the expression of ID2 by RNA interference could down-regulate the expression of Snail, suggesting that ID2-promoted cell growth, partially attributing to the regulation of Snail activity in NPC. Our study demonstrated that over-expression of ID2 protein is an unfavorable prognostic factor which promotes cell proliferation in NPC.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22551584     DOI: 10.1093/abbs/gms030

Source DB:  PubMed          Journal:  Acta Biochim Biophys Sin (Shanghai)        ISSN: 1672-9145            Impact factor:   3.848


  4 in total

1.  Inhibitor of DNA binding 2 is a novel therapeutic target for stemness of head and neck squamous cell carcinoma.

Authors:  Woo Jin Bae; Bon Seok Koo; Sang Hyuk Lee; Jin Man Kim; Young Soo Rho; Jae Yol Lim; Jung Hwa Moon; Jae Hoon Cho; Young Chang Lim
Journal:  Br J Cancer       Date:  2017-11-02       Impact factor: 7.640

2.  Reduced CTGF expression promotes cell growth, migration, and invasion in nasopharyngeal carcinoma.

Authors:  Yan Zhen; Yanfen Ye; Xiaoli Yu; Chunping Mai; Ying Zhou; Yan Chen; Huiling Yang; Xiaoming Lyu; Ye Song; Qiangyun Wu; Qiaofen Fu; Mengyang Zhao; Shengni Hua; Hao Wang; Zhen Liu; Yajie Zhang; Weiyi Fang
Journal:  PLoS One       Date:  2013-06-03       Impact factor: 3.240

3.  Genomic analysis of diffuse intrinsic pontine gliomas identifies three molecular subgroups and recurrent activating ACVR1 mutations.

Authors:  Pawel Buczkowicz; Christine Hoeman; Patricia Rakopoulos; Sanja Pajovic; Louis Letourneau; Misko Dzamba; Andrew Morrison; Peter Lewis; Eric Bouffet; Ute Bartels; Jennifer Zuccaro; Sameer Agnihotri; Scott Ryall; Mark Barszczyk; Yevgen Chornenkyy; Mathieu Bourgey; Guillaume Bourque; Alexandre Montpetit; Francisco Cordero; Pedro Castelo-Branco; Joshua Mangerel; Uri Tabori; King Ching Ho; Annie Huang; Kathryn R Taylor; Alan Mackay; Anne E Bendel; Javad Nazarian; Jason R Fangusaro; Matthias A Karajannis; David Zagzag; Nicholas K Foreman; Andrew Donson; Julia V Hegert; Amy Smith; Jennifer Chan; Lucy Lafay-Cousin; Sandra Dunn; Juliette Hukin; Chris Dunham; Katrin Scheinemann; Jean Michaud; Shayna Zelcer; David Ramsay; Jason Cain; Cameron Brennan; Mark M Souweidane; Chris Jones; C David Allis; Michael Brudno; Oren Becher; Cynthia Hawkins
Journal:  Nat Genet       Date:  2014-04-06       Impact factor: 38.330

4.  High bone marrow ID2 expression predicts poor chemotherapy response and prognosis in acute myeloid leukemia.

Authors:  Jing-Dong Zhou; Ji-Chun Ma; Ting-Juan Zhang; Xi-Xi Li; Wei Zhang; De-Hong Wu; Xiang-Mei Wen; Zi-Jun Xu; Jiang Lin; Jun Qian
Journal:  Oncotarget       Date:  2017-09-01
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.